6 - lung fibrosis treatment Flashcards

(30 cards)

1
Q

methods to monitor IPF progression

A

pulmonary function tests

thoracic imaging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

example of types of pulmonary function tests

A
forced vital capacity 
diffusion capacity of the lungs 
forced expiratory volume (FEV)
oxyhaemoglobin saturation 
6-minute walk test
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

method for thoracic imaging

A

high resolution CT scan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

only possible cure for IPF

A

lung transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

why is palliative care important for IPF

A

IPF is almost always a terminal disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

methods to diagnose IPF

A

listening for crackles through stethoscope
thoracic imaging
lung function tests
BAL fluid

endoscopic lung biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

results of 6 min walk test

A

often only 250m for IPF patients

should be around 700m

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

treatment strategies for IPF

A

proton pump inhibitor (PPI)
anti-coagulants
pharmaceuticals
pulmonary rehabilitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

example of proton pump inhibitor (PPI) to treat IPF

A

omeprazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

aim of omeprazole

A

proton pump inhibitor

reduce stomach acid made in the stomach for reflux to reduce coughing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

types of pharmaceutical therapies used to treat IPF

A

tyrosine kinase inhibitor (nintedanib)

antifibrotic agent (pirfendione)

antiviral therapies (ganciclovir)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

nintedanib

A

RTK inhibitor
blocks downstream signalling by inhibitiing cytokine receptors
slows disease progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

mechanism underlying nintedanib

A

if tyrosine kinase receptor is inhibited
cytokines (e.g. PDGF/VEGF/FGF) cannot act
therfore fibroblast proliferation is inhibited and inflammation is reduced
slows disease progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

testing for the presence of viruses in IPF

A

molecular techniques such as PCR, qPCR

testing for presence of antibodies –> shows past exposure to virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

why is therapy for IPF important

A

no realistic cure currently

main aim is to relieve symptoms and slow progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

pirfenidone

A

slows development of scarring in the lungs by reducing the immune response

17
Q

N-acetylcysteine

A

slows progression of IPF
anti-oxidant

loosens thick mucous

18
Q

other potenetial targets for anti-fibrotic drugs

A
CYTOKINES (IL-3, IL-21), chemokines
angiogenic factors (VEGF)
growth fators
acute phase proteins
caspases
19
Q

non-pharmaceutical treatment methods

A

improve lifestyle
oxygen therapy
pulmonary rehabilitations
lung transplant

20
Q

methods to improve lifestyle

A

–> stop smoking, exercise regularly, eat healthily, have seasonal vaccinations

21
Q

pulmonary rehabilitation methods

A

physical exercises
breathing exercises e.g.singing
psychological and social support
education about IPF

22
Q

importance of oxygen therapy

A

blood oxygen decreases in IPF causing breathlessness

treatment allows patient to be more active

23
Q

method of oxygen therapy

A

via nasal tube or mask attached to machine

24
Q

current clinical trials for IPF treatment

A

one trial on TGF-beta 1
one on FG-3019 –> shows reduction in fibrosis in animal models
research into steroids to exert anti-inflammatory effects

25
ganciclover
anti-viral therapy | shows promising effects when combined with standard therapy
26
why are animal studies important
used to demonstrate how, during latency, herpesvirus infections reprogram lung epithelial cells to produce profibrotic factors making lungs more susceptible to fibrotic insult
27
median survival of IPF patients
2-3 years
28
common name for PPI drugs
antacids
29
FGF
fibroblast growth factor
30
effect of nintedinab action
fibroblast proliferation is inhibited and inflammation is reduced slows disease progression